Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$9.89 - $13.64 $1,038 - $1,432
-105 Reduced 0.85%
12,213 $166,000
Q4 2023

Feb 13, 2024

SELL
$8.57 - $11.06 $11,663 - $15,052
-1,361 Reduced 9.95%
12,318 $134,000
Q3 2023

Nov 13, 2023

BUY
$10.95 - $14.6 $4,150 - $5,533
379 Added 2.85%
13,679 $149,000
Q2 2023

Aug 04, 2023

BUY
$12.93 - $18.05 $5,042 - $7,039
390 Added 3.02%
13,300 $176,000
Q1 2023

May 12, 2023

BUY
$13.02 - $22.62 $651 - $1,131
50 Added 0.39%
12,910 $175,000
Q4 2022

Feb 10, 2023

SELL
$17.77 - $21.6 $1,830 - $2,224
-103 Reduced 0.79%
12,860 $251,000
Q3 2022

Nov 14, 2022

BUY
$18.6 - $27.25 $8,481 - $12,426
456 Added 3.65%
12,963 $247,000
Q2 2022

Aug 12, 2022

BUY
$16.57 - $35.1 $15,642 - $33,134
944 Added 8.16%
12,507 $258,000
Q1 2022

May 13, 2022

BUY
$31.92 - $47.45 $26,493 - $39,383
830 Added 7.73%
11,563 $372,000
Q4 2021

Feb 11, 2022

SELL
$26.23 - $47.86 $8,419 - $15,363
-321 Reduced 2.9%
10,733 $500,000
Q3 2021

Nov 12, 2021

SELL
$23.91 - $29.58 $6,288 - $7,779
-263 Reduced 2.32%
11,054 $298,000
Q2 2021

Aug 13, 2021

SELL
$17.9 - $36.1 $3,311 - $6,678
-185 Reduced 1.61%
11,317 $290,000
Q1 2021

May 07, 2021

BUY
$30.86 - $44.2 $153,991 - $220,558
4,990 Added 76.63%
11,502 $393,000
Q4 2020

Feb 12, 2021

BUY
$21.59 - $33.95 $2,612 - $4,107
121 Added 1.89%
6,512 $220,000
Q3 2020

Nov 04, 2020

BUY
$17.57 - $32.92 $112,289 - $210,391
6,391 New
6,391 $158,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $363M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.